Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Differential Test for Flu A and B

By HospiMedica staff writers
Posted on 01 Nov 2000
A rapid in vitro assay for the direct and qualitative detection of influenza A and B viral antigens has the ability to distinguish the viral antigens of influenza A from those of influenza B, allowing for timely and proper treatment.

The assay was developed by Becton, Dickinson and Company (Sparks, MD, USA). More...
The company says it is an important advance in therapeutic decision-making for several reasons. One is that some antiviral therapies are effective only for influenza A, while others may be used to treat both strains. Thus, the assay can help clarify which treatment should be given. Second, antiviral agents must be given within the first 48 hours of illness to be effective. A test that provides results in 15 minutes promotes such treatment.

The test is an enzyme immunoassay membrane test that can be used with a variety of specimens, such as nasopharyngeal wash, nasopharyngeal aspirate, lower nasal swab, or throat swab. Easy-to-read results are determined by visual color development in the ColorPAC wells of the test device. The development of a purple triangle on the membrane in either the A or B well indicates a positive test. The test is called the BD Directigen Flu A+B.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.